Population-Wide Screening for Chronic Kidney Disease

Affiliations

¹ Department of Health Policy, Stanford School of Medicine, and Stanford Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, California.
² VA Palo Alto Health Care System, Center for Innovation to Implementation, Menlo Park, California.
³ Stanford Health Policy, Freeman Spogli Institute for International Studies, and Department of Health Policy, Department of Epidemiology and Population Health, and Division of Nephrology, Department of Medicine, Stanford School of Medicine, Stanford, California.

Comment

Marika M Cusick et al. Ann Intern Med. 2024 Jan.

. 2024 Jan;177(1):eL230370.

doi: 10.7326/L23-0370.

¹ Department of Health Policy, Stanford School of Medicine, and Stanford Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, California.
² VA Palo Alto Health Care System, Center for Innovation to Implementation, Menlo Park, California.
³ Stanford Health Policy, Freeman Spogli Institute for International Studies, and Department of Health Policy, Department of Epidemiology and Population Health, and Division of Nephrology, Department of Medicine, Stanford School of Medicine, Stanford, California.

No abstract available

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L23-0370.

Population-Wide Screening for Chronic Kidney Disease.
van Mil D, Heerspink HL, Gansevoort RT. van Mil D, et al. Ann Intern Med. 2024 Jan;177(1):eL230369. doi: 10.7326/L23-0369. Ann Intern Med. 2024. PMID: 38224605 No abstract available.